Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie H Oestreich

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Drug Targets|July 2, 2011
Progress of antiplatelet pharmacogenomicsJulie H Oestreich
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic eventsJulie H Oestreich
Currents in Pharmacy Teaching & Learning|September 26, 2022
A novel game to review pharmacoeconomic content in a pharmacy programAkesha Edwards, Julie H Oestreich
Current Drug Targets|February 4, 2012
Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptorsMatthew L Kelso, Julie H Oestreich
Pharmacy (Basel, Switzerland)|June 27, 2023
Technology Personalities in the Classroom: A New Classification System of TechTypes from Expert to Techy TurtleJulie H Oestreich, Jason W Guy
Expert Review of Clinical Pharmacology|January 14, 2014
Cangrelor in percutaneous coronary interventionJulie H Oestreich, Steven R Steinhubl
Journal of Pharmacy Practice|November 23, 2012
Novel direct-acting anticoagulants for risk reduction in ACSPaul P Dobesh, Julie H Oestreich
Pharmacotherapy|August 29, 2014
Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safetyPaul P Dobesh, Julie H Oestreich
Pharmacy (Basel, Switzerland)|January 25, 2022
Game-Based Learning in Pharmacy EducationJulie H Oestreich, Jason W Guy
Future Cardiology|April 26, 2014
Cangrelor for treatment during percutaneous coronary interventionJulie H Oestreich, Paul P Dobesh
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Drug Targets|July 2, 2011
Progress of antiplatelet pharmacogenomicsJulie H Oestreich
Current Opinion in Investigational Drugs (London, England : 2000)|February 24, 2010
Elinogrel, a reversible P2Y12 receptor antagonist for the treatment of acute coronary syndrome and prevention of secondary thrombotic eventsJulie H Oestreich
Currents in Pharmacy Teaching & Learning|September 26, 2022
A novel game to review pharmacoeconomic content in a pharmacy programAkesha Edwards, Julie H Oestreich
Current Drug Targets|February 4, 2012
Traumatic brain injury: central and peripheral role of α7 nicotinic acetylcholine receptorsMatthew L Kelso, Julie H Oestreich
Pharmacy (Basel, Switzerland)|June 27, 2023
Technology Personalities in the Classroom: A New Classification System of TechTypes from Expert to Techy TurtleJulie H Oestreich, Jason W Guy
Expert Review of Clinical Pharmacology|January 14, 2014
Cangrelor in percutaneous coronary interventionJulie H Oestreich, Steven R Steinhubl
Journal of Pharmacy Practice|November 23, 2012
Novel direct-acting anticoagulants for risk reduction in ACSPaul P Dobesh, Julie H Oestreich
Pharmacotherapy|August 29, 2014
Ticagrelor: pharmacokinetics, pharmacodynamics, clinical efficacy, and safetyPaul P Dobesh, Julie H Oestreich
Pharmacy (Basel, Switzerland)|January 25, 2022
Game-Based Learning in Pharmacy EducationJulie H Oestreich, Jason W Guy
Future Cardiology|April 26, 2014
Cangrelor for treatment during percutaneous coronary interventionJulie H Oestreich, Paul P Dobesh
Pageof 3